SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $94,000 | +16.0% | 4,950 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $81,000 | +9.5% | 4,950 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $74,000 | +68.2% | 4,950 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $44,000 | +69.2% | 4,950 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $26,000 | +73.3% | 4,950 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $15,000 | -34.8% | 4,950 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $23,000 | -20.7% | 4,950 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $29,000 | -3.3% | 4,950 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $30,000 | -33.3% | 4,950 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $45,000 | +60.7% | 4,950 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $28,000 | -49.1% | 4,950 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $55,000 | -29.5% | 4,950 | 0.0% | 0.00% | -42.9% |
| Q1 2015 | $78,000 | +4.0% | 4,950 | 0.0% | 0.01% | -22.2% |
| Q4 2014 | $75,000 | +41.5% | 4,950 | 0.0% | 0.01% | +12.5% |
| Q3 2014 | $53,000 | -30.3% | 4,950 | 0.0% | 0.01% | -42.9% |
| Q2 2014 | $76,000 | -14.6% | 4,950 | 0.0% | 0.01% | -33.3% |
| Q1 2014 | $89,000 | – | 4,950 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |